GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oncodesign Precision Medicine SA (XPAR:ALOPM) » Definitions » Price-to-Tangible-Book

Oncodesign Precision Medicine (XPAR:ALOPM) Price-to-Tangible-Book : (As of May. 30, 2025)


View and export this data going back to 2022. Start your Free Trial

What is Oncodesign Precision Medicine Price-to-Tangible-Book?

As of today (2025-05-30), Oncodesign Precision Medicine's share price is €0.33. Oncodesign Precision Medicine's Tangible Book per Share of Dec. 2024 for the quarter that ended in Dec. 2024 was €-0.08. Hence, Oncodesign Precision Medicine's Price to Tangible Book Ratio of today is .

The historical rank and industry rank for Oncodesign Precision Medicine's Price-to-Tangible-Book or its related term are showing as below:

During the past 5 years, Oncodesign Precision Medicine's highest Price to Tangible Book Ratio was 11.83. The lowest was 2.57. And the median was 7.20.

XPAR:ALOPM's Price-to-Tangible-Book is not ranked *
in the Biotechnology industry.
Industry Median: 2.785
* Ranked among companies with meaningful Price-to-Tangible-Book only.

A closely related ratio is called PB Ratio. As of today, Oncodesign Precision Medicine's share price is €0.33. Oncodesign Precision Medicine's Book Value per Sharefor the quarter that ended in Dec. 2024 was €-0.02. Hence, Oncodesign Precision Medicine's P/B Ratio of today is .

Oncodesign Precision Medicine Price-to-Tangible-Book Historical Data

The historical data trend for Oncodesign Precision Medicine's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oncodesign Precision Medicine Price-to-Tangible-Book Chart

Oncodesign Precision Medicine Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24
Price-to-Tangible-Book
- - 2.57 11.83 -

Oncodesign Precision Medicine Semi-Annual Data
Dec20 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Price-to-Tangible-Book Get a 7-Day Free Trial 2.57 3.22 11.83 - -

Competitive Comparison of Oncodesign Precision Medicine's Price-to-Tangible-Book

For the Biotechnology subindustry, Oncodesign Precision Medicine's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Oncodesign Precision Medicine's Price-to-Tangible-Book Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Oncodesign Precision Medicine's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Oncodesign Precision Medicine's Price-to-Tangible-Book falls into.


;
;

Oncodesign Precision Medicine Price-to-Tangible-Book Calculation

Oncodesign Precision Medicine's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book=Share Price/Tangible Book per Share (Q: Dec. 2024 )
=0.33/-0.083
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

Price to Tangible Book=Market Cap/Tangible Equity
=Market Cap/(Total Stockholders Equity-Preferred Stock-Intangible Assets)

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.

Oncodesign Precision Medicine Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Oncodesign Precision Medicine's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.

Oncodesign Precision Medicine Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oncodesign Precision Medicine SA (XPAR:ALOPM) » Definitions » Price-to-Tangible-Book
Comparable Companies
XPAR:ALTAO XPAR:ALTME XPAR:ALTHX XPAR:ALINT XPAR:ALVIO XPAR:ALBPS XPAR:ALPAT XPAR:ALNFL XPAR:ALNEV XPAR:ALCOX VRTX ASX:CSL REGN XKRX:207940 ALNY XBRU:ARGX XBRU:UCB ONC XKRX:068270 BNTX
Traded in Other Exchanges
N/A
Address
18 rue Jean Mazen, Dijon, FRA, 21000
Website
https://www.opm.oncodesign.com
Oncodesign Precision Medicine SA is a biopharmaceutical company specialised in precision medicine. Its mission is to provide patients with effective diagnostic and therapeutic solutions for resistant and metastatic cancers.

Oncodesign Precision Medicine Headlines

No Headlines